pillbase.ru

Xalkori

Active substance: crizotinib

crizotinib

Centralised EU authorisationActive

Marketing holder: Pfizer Europe MA EEIG

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
US 5
  • Xalkori
    CAPSULE, COATED PELLETS · CRIZOTINIB 20 mg/1
    0069-0251
    Pfizer Laboratories Div Pfizer Inc
  • Xalkori
    CAPSULE, COATED PELLETS · CRIZOTINIB 50 mg/1
    0069-0507
    Pfizer Laboratories Div Pfizer Inc
  • Xalkori
    CAPSULE · CRIZOTINIB 200 mg/1
    0069-8141
    Pfizer Laboratories Div Pfizer Inc
  • Xalkori
    CAPSULE · CRIZOTINIB 250 mg/1
    0069-8140
    Pfizer Laboratories Div Pfizer Inc
  • Xalkori
    CAPSULE, COATED PELLETS · CRIZOTINIB 150 mg/1
    0069-1500
    Pfizer Laboratories Div Pfizer Inc
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208c-3967-7cc9-8296-453bada0c7a6,01a1208c-e870-70fe-b3cb-ce5b9bcc3c00,01a1208c-f5b8-79cc-bfed-f43f3fc65d27,01a1208f-7e11-70f9-9756-68fd5acf2da9,01a12093-2cdc-7126-a7ee-3525369f574d;count=5 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
EMEA/H/C/002489
Registration status
Active
ATC code
L01ED01
Sources
  • product · EMA · EMEA/H/C/002489 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/002489 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/002489 · Verified 2026-10-09